OceanTech Acquisitions I said $30,000 was deposited into the company’s trust to extend its completion deadline until April 2.
Shareholders approved the deal last month, with REgentis Biomaterials although final redemptions reached 99.9% and there is a $6 million minimum cash condition to close the deal, according to the amended proxy filed in January. Following the merger vote, the SPAC had about $143,000 remaining in trust.
OceanTech’s sponsor has agreed to use reasonable best efforts to raise additional funding via a 파이프.
Israel-based Regentis is a regenerative medicine company developing tissue repair solutions. 자세히 보기.
- SEO 기반 콘텐츠 및 PR 배포. 오늘 증폭하십시오.
- PlatoData.Network 수직 생성 Ai. 자신에게 권한을 부여하십시오. 여기에서 액세스하십시오.
- PlatoAiStream. 웹3 인텔리전스. 지식 증폭. 여기에서 액세스하십시오.
- 플라톤ESG. 탄소, 클린테크, 에너지, 환경, 태양광, 폐기물 관리. 여기에서 액세스하십시오.
- PlatoHealth. 생명 공학 및 임상 시험 인텔리전스. 여기에서 액세스하십시오.
- 출처: https://spacfeed.com/oceantech-acquisitions-i-extends-deadline-by-another-month-as-it-works-to-close-shareholder-approved-regentis-deal
